
GW Pharmaceuticals plc GWPH
GW Pharmaceuticals plc DPO Ratio 2011-2026 | GWPH
Annual DPO Ratio GW Pharmaceuticals plc
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|
| 213 | 134 | 594 | 599 | 461 | 529 | 415 | 971 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 971 | 134 | 489 |
DPO Ratio of other stocks in the Biotechnology industry
| Issuer | DPO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
5.06 K | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
5.24 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
2.24 K | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
78.2 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
265 | - | - | $ 96.9 B | ||
|
Midatech Pharma plc
MTP
|
162 | - | -18.52 % | $ 27.3 M | ||
|
Esperion Therapeutics
ESPR
|
7.93 K | $ 3.13 | - | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
74.3 | $ 35.0 | 1.6 % | $ 942 M | ||
|
Институт стволовых клеток человека
ISKJ
|
115 | - | - | - | ||
|
Celyad Oncology SA
CYAD
|
55.8 K | - | - | $ 12.5 M | ||
|
Berkeley Lights
BLI
|
135 | - | -7.31 % | $ 87 M | ||
|
Autolus Therapeutics plc
AUTL
|
9.57 | $ 1.65 | 1.85 % | $ 439 M | ||
|
Ayala Pharmaceuticals
AYLA
|
2.21 K | - | - | $ 7.46 M | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.79 K | - | -4.36 % | $ 27 M | ||
|
Heron Therapeutics
HRTX
|
91.4 | $ 0.87 | 3.09 % | $ 145 M | ||
|
Compugen Ltd.
CGEN
|
82.7 | $ 2.61 | -3.51 % | $ 244 M | ||
|
Anika Therapeutics
ANIK
|
43.4 | $ 15.02 | -0.79 % | $ 215 M | ||
|
Advaxis
ADXS
|
85.6 K | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
34.4 K | - | 5.93 % | $ 314 M | ||
|
Incyte Corporation
INCY
|
200 | $ 97.41 | 0.34 % | $ 19 B | ||
|
Ionis Pharmaceuticals
IONS
|
815 | $ 75.78 | 0.96 % | $ 12.1 B | ||
|
AIkido Pharma
AIKI
|
1.92 | - | 1.93 % | $ 17.4 M | ||
|
Coherus BioSciences
CHRS
|
507 | $ 1.57 | 3.97 % | $ 184 M | ||
|
Albireo Pharma
ALBO
|
1.59 K | - | -0.23 % | $ 916 M | ||
|
Arcutis Biotherapeutics
ARQT
|
133 | $ 21.01 | 2.64 % | $ 2.67 B |